{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:42:43Z","timestamp":1778125363077,"version":"3.51.4"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.28971","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:33:59Z","timestamp":1634164439000},"page":"e2128971","source":"Crossref","is-referenced-by-count":21,"title":["Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance"],"prefix":"10.1001","volume":"4","author":[{"given":"Joacy G.","family":"Mathias","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikki G.","family":"Nolan","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Klesges","sequence":"additional","affiliation":[{"name":"Department of Surgery, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif M.","family":"Badawy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William O.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University, Nashville, Tennessee"},{"name":"Department of Health Policy, Vanderbilt University, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane S.","family":"Hankins","sequence":"additional","affiliation":[{"name":"Department of Hematology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Smeltzer","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, The University of Memphis, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"issue":"1","key":"zld210212r1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/16078454.2018.1549801","article-title":"Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study.","volume":"24","author":"Cronin","year":"2019","journal-title":"Hematology"},{"issue":"10","key":"zld210212r2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ajh.v85:10","article-title":"Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.","volume":"85","author":"Stallworth","year":"2010","journal-title":"Am J Hematol"},{"key":"zld210212r3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13104-015-1344-0","article-title":"Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.","volume":"8","author":"Creary","year":"2015","journal-title":"BMC Res Notes"},{"issue":"8","key":"zld210212r4","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27778","article-title":"Hydroxyurea for children with sickle cell anemia: Prescribe it early and often.","volume":"66","author":"Ware","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"zld210212r5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3285","article-title":"Hydroxyurea use for sickle cell disease among Medicaid-enrolled children.","volume":"144","author":"Brousseau","year":"2019","journal-title":"Pediatrics"},{"issue":"2","key":"zld210212r6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/(ISSN)1096-8652","article-title":"Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature.","volume":"60","author":"Diav-Citrin","year":"1999","journal-title":"Am J Hematol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784920\/mathias_2021_ld_210212_1633112292.67145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:34:03Z","timestamp":1634164443000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28971","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]}}}